Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for PEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 443.96M
March 31, 2026 424.63M
December 31, 2025 398.92M
September 30, 2025 385.67M
June 30, 2025 380.86M
March 31, 2025 380.42M
December 31, 2024 382.25M
September 30, 2024 374.84M
June 30, 2024 373.33M
March 31, 2024 376.31M
December 31, 2023 377.36M
September 30, 2023 364.24M
June 30, 2023 365.99M
March 31, 2023 370.83M
December 31, 2022 372.03M
September 30, 2022 347.85M
June 30, 2022 357.88M
March 31, 2022 342.27M
December 31, 2021 290.32M
September 30, 2021 288.64M
June 30, 2021 236.84M
March 31, 2021 190.35M
December 31, 2020 185.20M
Date Value
September 30, 2020 190.59M
June 30, 2020 157.04M
March 31, 2020 176.12M
December 31, 2019 180.29M
September 30, 2019 147.23M
June 30, 2019 130.93M
March 31, 2019 132.13M
December 31, 2018 92.59M
September 30, 2018 91.72M
June 30, 2018 74.12M
March 31, 2018 74.79M
December 31, 2017 79.56M
September 30, 2017 75.26M
June 30, 2017 44.02M
March 31, 2017 44.89M
December 31, 2016 41.71M
September 30, 2016 43.42M
June 30, 2016 36.39M
March 31, 2016 37.07M
December 31, 2015 31.33M
September 30, 2015 30.74M
June 30, 2015 28.70M
March 31, 2015 25.94M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Boston Scientific Corp. 20.04B
Globus Medical, Inc. 719.66M
Abbott Laboratories 57.45B
AngioDynamics, Inc. 96.34M
Teleflex, Inc. 3.882B

Total Liabilities (Quarterly) Related Metrics